Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

References

Page 1

	Year	Citations
The Liver: Biology and Pathobiology William D. Carey JAMA Excellent BooksPathologyUndergo Differential TurnoverFatty Liver DiseaseCholangiopathies	1983	491
CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species Yoshio Tsujita, Masao Kuroda, Yoko Shimada, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism OxysterolBiochemistryMedicineLipoprotein MetabolismHypolipidemic Effect	1986	374
Inhibition of Cholesterol Synthesis <i>in vitro</i> and <i>in vivo</i> by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase Akira Endo, Yoshio Tsujita, Masao Kuroda, European Journal of Biochemistry OxysterolPharmacological StudyBiochemistryLiver SlicesMedicine	1977	263
Rates of sterol synthesis and uptake in the major organs of the rat in vivo. S D Turley, John M. Andersen, John M. Dietschy Journal of Lipid Research Animal PhysiologyTissue SterolsAdrenal GlandOxysterolBiochemistry	1981	217
Measurement of rates of cholesterol synthesis using tritiated water John M. Dietschy, D K Spady Journal of Lipid Research Lipid AnalysisOxysterolLipid SynthesisBiochemistryHmg-coa Reductase	1984	201
Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus Bruce D. Roth, C. John Blankley, Alexander Chucholowski, Journal of Medicinal Chemistry	1991	183
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo John I. Germershausen, V. M. Hunt, Richard G. Bostedor, Biochemical and Biophysical Research Communications InflammationCholesterol-lowering Agents LovastatinCardiovascular DiseaseMedicinePhysiology	1989	172
Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Teiichiro Koga, Yohko Shimada, Masao Kuroda, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Tissue-selective InhibitionPravastatin SodiumOxysterolBiochemistryMedicine	1990	168
Absolute rates of cholesterol synthesis in extrahepatic tissues measured with 3H-labeled water and 14C-labeled substrates. John M. Andersen, John Dietschy Journal of Lipid Research	1979	156
The physiological disposition of lovastatin. D E Duggan, I W Chen, W.F. Bayne, Drug Metabolism and Disposition	1989	124

Page 1